OTC Healthcare in the Netherlands to 2013

Introduction

This databook provides key data and information on the OTC healthcare market in the Netherlands. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.

Scope

*Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits

*Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data

*Category level company and brand share as well as distribution share information for 2007 and 2008

*Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights

The market for OTC healthcare in the Netherlands increased at a compound annual growth rate of 2.9% between 2003 and 2008.

The vitamins and minerals category led the OTC healthcare market in the Netherlands, accounting for a share of 22%.

Leading players in the Dutch OTC healthcare market include Johnson & Johnson, Bayer AG and Novartis AG.

Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the OTC healthcare market in the Netherlands

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements


Report Highlights

[Fade out the market survey infos]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary market level: OTC healthcare 2
Summary category level: analgesics 3
Summary category level: topical OTC medicines 4
Summary category level: cough and cold preparations 5
Summary category level: indigestion preparations 6
Summary category level: medicated skin products 7
Summary category level: first aid kits 8
Summary category level: other OTC healthcare products 9
Summary category level: plasters & bandages 10
Summary category level: traditional medicines 11
Summary category level: vitamins and minerals 12
Chapter 2 Introduction 13
What is this report about? 13
How to use this report 13
Market definition 14
Chapter 3 Market Overview 32
Value analysis (Euro), 2003?08 32
Value analysis (Euro), 2008?13 34
Value analysis (US dollars), 2003?08 36
Value analysis (US dollars), 2008?13 37
Company and brand share analysis 39
Distribution analysis 46
Chapter 4 Leading Company Profiles 48
Johnson & Johnson 48
Bayer AG 50
Chapter 5 Category Analysis: Analgesics 53
Value analysis (Euro), 2003?08 53
Value analysis (Euro), 2008?13 54
Value analysis (US dollars), 2003?08 56
Value analysis (US dollars), 2008?13 57
Company and brand share analysis 59
Distribution analysis 62
Chapter 6 Category Analysis: Topical OTC Medicines 64
Value analysis (Euro), 2003?08 64
Value analysis (Euro), 2008?13 65
Value analysis (US dollars), 2003?08 67
Value analysis (US dollars), 2008?13 68
Company and brand share analysis 70
Distribution analysis 72
Chapter 7 Category Analysis: Cough and Cold Preparations 74
Value analysis (Euro), 2003?08 74
Value analysis (Euro), 2008?13 75
Value analysis (US dollars), 2003?08 77
Value analysis (US dollars), 2008?13 78
Company and brand share analysis 80
Distribution analysis 83
Chapter 8 Category Analysis: Indigestion Preparations 85
Value analysis (Euro), 2003?08 85
Value analysis (Euro), 2008?13 86
Value analysis (US dollars), 2003?08 88
Value analysis (US dollars), 2008?13 88
Company and brand share analysis 90
Distribution analysis 93
Chapter 9 Category Analysis: Medicated Skin Products 95
Value analysis (Euro), 2003?08 95
Value analysis (Euro), 2008?13 96
Value analysis (US dollars), 2003?08 98
Value analysis (US dollars), 2008?13 99
Company and brand share analysis 101
Distribution analysis 104
Chapter 10 Category Analysis: First Aid Kits 106
Value analysis (Euro), 2003?08 106
Value analysis (Euro), 2008?13 107
Value analysis (US dollars), 2003?08 108
Value analysis (US dollars), 2008?13 108
Company and brand share analysis 109
Distribution analysis 112
Chapter 11 Category Analysis: Other OTC Healthcare Products 114
Value analysis (Euro), 2003?08 114
Value analysis (Euro), 2008?13 115
Value analysis (US dollars), 2003?08 117
Value analysis (US dollars), 2008?13 118
Company and brand share analysis 120
Distribution analysis 124
Chapter 12 Category Analysis: Plasters & Bandages 126
Value analysis (Euro), 2003?08 126
Value analysis (Euro), 2008?13 127
Value analysis (US dollars), 2003?08 129
Value analysis (US dollars), 2008?13 130
Company and brand share analysis 132
Distribution analysis 135
Chapter 13 Category Analysis: Traditional Medicines 137
Value analysis (Euro), 2003?08 137
Value analysis (Euro), 2008?13 138
Value analysis (US dollars), 2003?08 139
Value analysis (US dollars), 2008?13 139
Company and brand share analysis 140
Distribution analysis 143
Chapter 14 Category Analysis: Vitamins and Minerals 145
Value analysis (Euro), 2003?08 145
Value analysis (Euro), 2008?13 146
Value analysis (US dollars), 2003?08 148
Value analysis (US dollars), 2008?13 148
Company and brand share analysis 150
Distribution analysis 153
Chapter 15 Country Comparison 155
Value 155
Market share 159
Chapter 16 PESTLE Analysis 160
Summary 160
Political analysis 161
Economic analysis 165
Social analysis 169
Technological analysis 173
Legal analysis 177
Environmental analysis 180
Chapter 17 New Product Development 184
Product launches over time 184
Recent product launches 186
Chapter 18 Macroeconomic Profile 187
Macroeconomic indicators 187
Chapter 19 Research Methodology 192
Methodology overview 192
Secondary research 193
Market modeling 194
Creating an initial data model 194
Revising the initial data model 194
Creating a final estimate 195
Creating demographic value splits 195
Primary research 195
Data finalization 196
Ongoing research 196
Chapter 20 APPENDIX 197
Future readings 197
How to contact experts in your industry 197
Disclaimerr 197

LIST OF FIGURES
Figure 1: Netherlands OTC healthcare value and value forecast, 2003?13 (€m, nominal prices) 35
Figure 2: Netherlands OTC healthcare category growth comparison, by value, 2003?13 38
Figure 3: Netherlands OTC healthcare company share, by value, 2007?08 (%) 43
Figure 4: Netherlands OTC healthcare distribution channels, by value, 2007?08 (%) 47
Figure 5: Netherlands analgesics value and value forecast, 2003?13 (€m, nominal prices) 55
Figure 6: Netherlands analgesics category growth comparison, by value, 2003?13 58
Figure 7: Netherlands analgesics company share, by value, 2007?08 (%) 60
Figure 8: Netherlands analgesics distribution channels, by value, 2007?08 (%) 63
Figure 9: Netherlands topical OTC medicines value and value forecast, 2003?13 (€m, nominal prices) 66
Figure 10: Netherlands topical OTC medicines category growth comparison, by value, 2003?13 69
Figure 11: Netherlands topical OTC medicines distribution channels, by value, 2007?08 (%) 73
Figure 12: Netherlands cough and cold preparations value and value forecast, 2003?13 (€m, nominal prices) 76
Figure 13: Netherlands cough and cold preparations category growth comparison, by value, 2003?13 79
Figure 14: Netherlands cough and cold preparations company share, by value, 2007?08 (%) 81
Figure 15: Netherlands cough and cold preparations distribution channels, by value, 2007?08 (%) 84
Figure 16: Netherlands indigestion preparations value and value forecast, 2003?13 (€m, nominal prices) 87
Figure 17: Netherlands indigestion preparations category growth comparison, by value, 2003?13 89
Figure 18: Netherlands indigestion preparations company share, by value, 2007?08 (%) 91
Figure 19: Netherlands indigestion preparations distribution channels, by value, 2007?08 (%) 94
Figure 20: Netherlands medicated skin products value and value forecast, 2003?13 (€m, nominal prices) 97
Figure 21: Netherlands medicated skin products category growth comparison, by value, 2003?13 100
Figure 22: Netherlands medicated skin products company share, by value, 2007?08 (%) 102
Figure 23: Netherlands medicated skin products distribution channels, by value, 2007?08 (%) 105
Figure 24: Netherlands first aid kits value and value forecast, 2003?13 (€m, nominal prices) 107
Figure 25: Netherlands first aid kits company share, by value, 2007?08 (%) 110
Figure 26: Netherlands first aid kits distribution channels, by value, 2007?08 (%) 113
Figure 27: Netherlands other OTC healthcare products value and value forecast, 2003?13 (€m, nominal prices) 116
Figure 28: Netherlands other OTC healthcare products category growth comparison, by value, 2003?13 119
Figure 29: Netherlands other OTC healthcare products company share, by value, 2007?08 (%) 122
Figure 30: Netherlands other OTC healthcare products distribution channels, by value, 2007?08 (%) 125
Figure 31: Netherlands plasters & bandages value and value forecast, 2003?13 (€m, nominal prices) 128
Figure 32: Netherlands plasters & bandages category growth comparison, by value, 2003?13 131
Figure 33: Netherlands plasters & bandages company share, by value, 2007?08 (%) 133
Figure 34: Netherlands plasters & bandages distribution channels, by value, 2007?08 (%) 136
Figure 35: Netherlands traditional medicines value and value forecast, 2003?13 (€m, nominal prices) 138
Figure 36: Netherlands traditional medicines company share, by value, 2007?08 (%) 141
Figure 37: Netherlands traditional medicines distribution channels, by value, 2007?08 (%) 144
Figure 38: Netherlands vitamins and minerals value and value forecast, 2003?13 (€m, nominal prices) 147
Figure 39: Netherlands vitamins and minerals category growth comparison, by value, 2003?13 149
Figure 40: Netherlands vitamins and minerals company share, by value, 2007?08 (%) 151
Figure 41: Netherlands vitamins and minerals distribution channels, by value, 2007?08 (%) 154
Figure 42: Global OTC healthcare market split (value terms, 2008), top five countries 156
Figure 43: Global OTC healthcare market value, 2003–08, top five countries 158
Figure 44: Annual data review process 193

LIST OF TABLES
Table 1: OTC healthcare category definitions 15
Table 2: OTC healthcare distribution channels 17
Table 3: Netherlands OTC healthcare value, 2003?08 (€m, nominal prices) 33
Table 4: Netherlands OTC healthcare value forecast, 2008?13 (€m, nominal prices) 34
Table 5: Netherlands OTC healthcare value, 2003?08 ($m, nominal prices) 36
Table 6: Netherlands OTC healthcare value forecast, 2008?13 ($m, nominal prices) 37
Table 7: Netherlands OTC healthcare brand share, by value, 2007?08 (%) 39
Table 8: Netherlands OTC healthcare value, by brand 2007?08 (€m, nominal prices) 41
Table 9: Netherlands OTC healthcare company share by value, 2007?08 (%) 44
Table 10: Netherlands OTC healthcare value, by company, 2007?08 (€m, nominal prices) 45
Table 11: Netherlands OTC healthcare distribution channels, by value, 2007?08 (%) 46
Table 12: Netherlands OTC healthcare value, by distribution channel, 2007?08 (€m, nominal prices) 46
Table 13: Johnson & Johnson key facts 48
Table 14: Bayer AG key facts 50
Table 15: Netherlands analgesics value, 2003?08 (€m, nominal prices) 53
Table 16: Netherlands analgesics value forecast, 2008?13 (€m, nominal prices) 54
Table 17: Netherlands analgesics value, 2003?08 ($m, nominal prices) 56
Table 18: Netherlands analgesics value forecast, 2008?13 ($m, nominal prices) 57
Table 19: Netherlands analgesics brand share, by value, 2007?08 (%) 59
Table 20: Netherlands analgesics value, by brand 2007?08 (€m, nominal prices) 59
Table 21: Netherlands analgesics company share by value, 2007?08 (%) 61
Table 22: Netherlands analgesics value, by company, 2007?08 (€m, nominal prices) 61
Table 23: Netherlands analgesics distribution channels, by value, 2007?08 (%) 62
Table 24: Netherlands analgesics value, by distribution channel, 2007?08 (€m, nominal prices) 62
Table 25: Netherlands topical OTC medicines value, 2003?08 (€m, nominal prices) 64
Table 26: Netherlands topical OTC medicines value forecast, 2008?13 (€m, nominal prices) 65
Table 27: Netherlands topical OTC medicines value, 2003?08 ($m, nominal prices) 67
Table 28: Netherlands topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 68
Table 29: Netherlands topical OTC medicines brand share, by value, 2007?08 (%) 70
Table 30: Netherlands topical OTC medicines value, by brand 2007?08 (€m, nominal prices) 70
Table 31: Netherlands topical OTC medicines company share by value, 2007?08 (%) 71
Table 32: Netherlands topical OTC medicines value, by company, 2007?08 (€m, nominal prices) 71
Table 33: Netherlands topical OTC medicines distribution channels, by value, 2007?08 (%) 72
Table 34: Netherlands topical OTC medicines value, by distribution channel, 2007?08 (€m, nominal prices) 72
Table 35: Netherlands cough and cold preparations value, 2003?08 (€m, nominal prices) 74
Table 36: Netherlands cough and cold preparations value forecast, 2008?13 (€m, nominal prices) 75
Table 37: Netherlands cough and cold preparations value, 2003?08 ($m, nominal prices) 77
Table 38: Netherlands cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 78
Table 39: Netherlands cough and cold preparations brand share, by value, 2007?08 (%) 80
Table 40: Netherlands cough and cold preparations value, by brand 2007?08 (€m, nominal prices) 80
Table 41: Netherlands cough and cold preparations company share by value, 2007?08 (%) 82
Table 42: Netherlands cough and cold preparations value, by company, 2007?08 (€m, nominal prices) 82
Table 43: Netherlands cough and cold preparations distribution channels, by value, 2007?08 (%) 83
Table 44: Netherlands cough and cold preparations value, by distribution channel, 2007?08 (€m, nominal prices) 83
Table 45: Netherlands indigestion preparations value, 2003?08 (€m, nominal prices) 85
Table 46: Netherlands indigestion preparations value forecast, 2008?13 (€m, nominal prices) 86
Table 47: Netherlands indigestion preparations value, 2003?08 ($m, nominal prices) 88
Table 48: Netherlands indigestion preparations value forecast, 2008?13 ($m, nominal prices) 88
Table 49: Netherlands indigestion preparations brand share, by value, 2007?08 (%) 90
Table 50: Netherlands indigestion preparations value, by brand 2007?08 (€m, nominal prices) 90
Table 51: Netherlands indigestion preparations company share by value, 2007?08 (%) 92
Table 52: Netherlands indigestion preparations value, by company, 2007?08 (€m, nominal prices) 92
Table 53: Netherlands indigestion preparations distribution channels, by value, 2007?08 (%) 93
Table 54: Netherlands indigestion preparations value, by distribution channel, 2007?08 (€m, nominal prices) 93
Table 55: Netherlands medicated skin products value, 2003?08 (€m, nominal prices) 95
Table 56: Netherlands medicated skin products value forecast, 2008?13 (€m, nominal prices) 96
Table 57: Netherlands medicated skin products value, 2003?08 ($m, nominal prices) 98
Table 58: Netherlands medicated skin products value forecast, 2008?13 ($m, nominal prices) 99
Table 59: Netherlands medicated skin products brand share, by value, 2007?08 (%) 101
Table 60: Netherlands medicated skin products value, by brand 2007?08 (€m, nominal prices) 101
Table 61: Netherlands medicated skin products company share by value, 2007?08 (%) 103
Table 62: Netherlands medicated skin products value, by company, 2007?08 (€m, nominal prices) 103
Table 63: Netherlands medicated skin products distribution channels, by value, 2007?08 (%) 104
Table 64: Netherlands medicated skin products value, by distribution channel, 2007?08 (€m, nominal prices) 104
Table 65: Netherlands first aid kits value, 2003?08 (€m, nominal prices) 106
Table 66: Netherlands first aid kits value forecast, 2008?13 (€m, nominal prices) 107
Table 67: Netherlands first aid kits value, 2003?08 ($m, nominal prices) 108
Table 68: Netherlands first aid kits value forecast, 2008?13 ($m, nominal prices) 108
Table 69: Netherlands first aid kits brand share, by value, 2007?08 (%) 109
Table 70: Netherlands first aid kits value, by brand 2007?08 (€m, nominal prices) 109
Table 71: Netherlands first aid kits company share by value, 2007?08 (%) 111
Table 72: Netherlands first aid kits value, by company, 2007?08 (€m, nominal prices) 111
Table 73: Netherlands first aid kits distribution channels, by value, 2007?08 (%) 112
Table 74: Netherlands first aid kits value, by distribution channel, 2007?08 (€m, nominal prices) 112
Table 75: Netherlands other OTC healthcare products value, 2003?08 (€m, nominal prices) 114
Table 76: Netherlands other OTC healthcare products value forecast, 2008?13 (€m, nominal prices) 115
Table 77: Netherlands other OTC healthcare products value, 2003?08 ($m, nominal prices) 117
Table 78: Netherlands other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 118
Table 79: Netherlands other OTC healthcare products brand share, by value, 2007?08 (%) 120
Table 80: Netherlands other OTC healthcare products value, by brand 2007?08 (€m, nominal prices) 121
Table 81: Netherlands other OTC healthcare products company share by value, 2007?08 (%) 123
Table 82: Netherlands other OTC healthcare products value, by company, 2007?08 (€m, nominal prices) 123
Table 83: Netherlands other OTC healthcare products distribution channels, by value, 2007?08 (%) 124
Table 84: Netherlands other OTC healthcare products value, by distribution channel, 2007?08 (€m, nominal prices) 124
Table 85: Netherlands plasters & bandages value, 2003?08 (€m, nominal prices) 126
Table 86: Netherlands plasters & bandages value forecast, 2008?13 (€m, nominal prices) 127
Table 87: Netherlands plasters & bandages value, 2003?08 ($m, nominal prices) 129
Table 88: Netherlands plasters & bandages value forecast, 2008?13 ($m, nominal prices) 130
Table 89: Netherlands plasters & bandages brand share, by value, 2007?08 (%) 132
Table 90: Netherlands plasters & bandages value, by brand 2007?08 (€m, nominal prices) 132
Table 91: Netherlands plasters & bandages company share by value, 2007?08 (%) 134
Table 92: Netherlands plasters & bandages value, by company, 2007?08 (€m, nominal prices) 134
Table 93: Netherlands plasters & bandages distribution channels, by value, 2007?08 (%) 135
Table 94: Netherlands plasters & bandages value, by distribution channel, 2007?08 (€m, nominal prices) 135
Table 95: Netherlands traditional medicines value, 2003?08 (€m, nominal prices) 137
Table 96: Netherlands traditional medicines value forecast, 2008?13 (€m, nominal prices) 138
Table 97: Netherlands traditional medicines value, 2003?08 ($m, nominal prices) 139
Table 98: Netherlands traditional medicines value forecast, 2008?13 ($m, nominal prices) 139
Table 99: Netherlands traditional medicines brand share, by value, 2007?08 (%) 140
Table 100: Netherlands traditional medicines value, by brand 2007?08 (€m, nominal prices) 140
Table 101: Netherlands traditional medicines company share by value, 2007?08 (%) 142
Table 102: Netherlands traditional medicines value, by company, 2007?08 (€m, nominal prices) 142
Table 103: Netherlands traditional medicines distribution channels, by value, 2007?08 (%) 143
Table 104: Netherlands traditional medicines value, by distribution channel, 2007?08 (€m, nominal prices) 143
Table 105: Netherlands vitamins and minerals value, 2003?08 (€m, nominal prices) 145
Table 106: Netherlands vitamins and minerals value forecast, 2008?13 (€m, nominal prices) 146
Table 107: Netherlands vitamins and minerals value, 2003?08 ($m, nominal prices) 148
Table 108: Netherlands vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 148
Table 109: Netherlands vitamins and minerals brand share, by value, 2007?08 (%) 150
Table 110: Netherlands vitamins and minerals value, by brand 2007?08 (€m, nominal prices) 150
Table 111: Netherlands vitamins and minerals company share by value, 2007?08 (%) 152
Table 112: Netherlands vitamins and minerals value, by company, 2007?08 (€m, nominal prices) 152
Table 113: Netherlands vitamins and minerals distribution channels, by value, 2007?08 (%) 153
Table 114: Netherlands vitamins and minerals value, by distribution channel, 2007?08 (€m, nominal prices) 153
Table 115: Global OTC healthcare market value, 2008 155
Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 158
Table 117: Leading players, top five countries 159
Table 118: Analysis of the Netherlands’s political landscape 161
Table 119: Analysis of the Netherlands’s economic landscape 165
Table 120: Analysis of the Netherlands’s social landscape 169
Table 121: Analysis of the Netherlands’s technology landscape 173
Table 122: Analysis of the Netherlands’s legal landscape 177
Table 123: Analysis of the Netherlands’s environmental landscape 180
Table 124: Netherlands OTC healthcare new product launches reports, by company (top five companies), 2008 184
Table 125: Netherlands OTC healthcare new product launches SKUs, by company (top five companies), 2008 184
Table 126: Netherlands OTC healthcare new product launches (reports), by flavor and fragrances, 2008 185
Table 127: Netherlands OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2008 185
Table 128: Netherlands OTC healthcare new product launches (reports), by package tags or claims ,2008 186
Table 129: Netherlands OTC healthcare new product launches - recent five launches 2008 186
Table 130: Netherlands population, by age group, 2003?08 (millions) 187
Table 131: Netherlands population forecast, by age group, 2008?13 (millions) 188
Table 132: Netherlands population, by gender, 2003?08 (millions) 188
Table 133: Netherlands population forecast, by gender, 2008?13 (millions) 189
Table 134: Netherlands nominal GDP, 2003?08 (€bn, nominal prices) 189
Table 135: Netherlands nominal GDP forecast, 2008?13 (€bn, nominal prices) 189
Table 136: Netherlands real GDP, 2003?08 (€bn, 2000 prices) 190
Table 137: Netherlands real GDP forecast, 2008?13 (€bn, 2000 prices) 190
Table 138: Netherlands real GDP, 2003?08 ($bn, 2000 prices) 190
Table 139: Netherlands real GDP forecast, 2008?13 ($bn, 2000 prices) 191
Table 140: Netherlands consumer price index, 2003?08 (2000=100) 191
Table 141: Netherlands consumer price index, 2008?13 (2000=100) 191



[Fade out table of contents]